Document is current
Any future updates will be listed below
-
Authors
,
Kone-Paut, Isabelle
Barete, Stéphane
Bodaghi, Bahram
Deiva, Kumaran
Desbois, Anne-Claire
Galeotti, Caroline
Gaudric, Julien
Kaplanski, Gilles
Mahr, Alfred
Noel, Nicolas
Piram, Maryam
Tran, Tu-Anh
Wechsler, Bertrand
Saadoun, David
- License Information
-
More Information
Article History
First Online: 24 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: IKP reports consulting fees/meeting fees from Novartis, Abbvie, SOBI, LFB; speaking fees from Novartis, SOBI, Pfizer, Zeste Research, LFB; and research funding from Novartis. SB, ACD, CG, JG, GK, NN and DS reports no conflicts of interest. BB reports consulting fees/meeting fees from Allergan, Santen, Abbvie, Alimera; speaking fees from Abbvie, Alimera. AM reports consulting fees/meeting fees from Celgène and speaking fees from Roche-Chugaï. MP reports consulting fees/meeting fees from Patent Valor and research funding from Novartis. TAT reports speaking fees from Abbvie and Roche-Chugaï.
